drugset / Trial / NCT00343655

Evaluation of Atorvastatin Treatment on Carotid Plaque.

NCT00343655 ↗

Phase 3 Terminated 160 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effect of 18 months treatment with atorvastatin 80mg or atorvastatin 10mg on the carotid vessel plaque morphology, in particular, the effect on evident necrotic lipid rich core of the plaque in patients.

Timeline

Start
2007-01
Primary completion
—
Completion
2007-08

Outcome

Outcome not reported

Stopped (Enrollment): “The study was terminated on June 22, 2007 for inability to enroll patients within an appropriate timeframe. There were no efficacy/safety concerns.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Atorvastatin Small molecule 80 mg —